Our Social Media Pages, follow us and engage with the Pill-grim community!

Join our Entre Community

Instagram

Twitter

YouTube

TikTok

LinkedIn

And now for this week’s prescription:

On this week’s dose, we start (1:58) with a breakdown on Decagon, an enterprise AI platform revolutionizing customer support, following their $65M Series B. Next (9:28), we dive into Abridge, a startup using AI to automate clinical documentation, backed by a recent $250M funding round. Finally (20:11) , we wrap up with a deep dive on Joby, a company developing electric air taxis for commercial passenger service, and their additional $500M investment from Toyota.

Sources:

https://decagon.ai/blog/series-b

https://www.abridge.com/

https://techcrunch.com/2024/06/18/how-abridge-became-one-of-the-most-talked-about-healthcare-ai-startups/?guccounter=1&guce_referrer=aHR0cHM6Ly93d3cuZ29vZ2xlLmNvbS8&guce_referrer_sig=AQAAALhF6BSj0lyZwC64cw-YB1qSaFwsl5fQBx9Q15snKLTn2J02SNzvontN6PVuSKRJiBNRZTx61UXxAzv1BC5UVLOBujaKES08ovmk859Z28za0j9HZNYL4GwEwzB-7hXaKMgjPJG1-M8ms6wXR2XcVdi1v32hX_3OaFoJBQ5VQlv0

https://siliconangle.com/2024/10/11/healthcare-ai-startup-abridge-reportedly-raising-250m-2-5b-valuation/

https://www.beckershospitalreview.com/digital-health/abridge-raising-250m-report.html

https://www.jobyaviation.com/

https://pressroom.toyota.com/toyota-to-invest-500-million-in-joby-aviation/

Music Credit: Chapter One by Cole Bauer and Dean Keeton

https://www.instagram.com/deankeeton/?hl=en

Disclosure:

The views, statements, and opinions, expressed herein by the hosts and guests are their own, and their appearance on the podcast should not be construed as reflecting the views or implied endorsement of Independent Brokerage Solutions LLC or any of its officers, employees, or agents. The statements made herein should not be considered an investment opinion, advice, or a recommendation regarding securities of any company. This podcast is produced solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy a security.

Our Social Media Pages, follow us and engage with the Pill-grim community!

Instagram

Twitter

YouTube

TikTok

LinkedIn

And now for this week’s prescription:

On this week’s dose, we mix things up a bit with a status update for Sam and Brandon. The 138 week streak of weekly doses may soon come to an end. With each of us moving to new cities, there just isn’t as much time in the week as there used to be when the pod was based out of Austin. Don’t worry! We aren’t going anywhere. You just might not see a dose every single Thursday morning.

The second half of this week’s dose is a conversational breakdown of Interplay Learning (the company Sam works for) and their recent fundraising round led by Goldman Sachs’ Inclusive Growth Fund. With that announcement, Interplay also welcomes ITI (Industrial Training International) to the family. Tune in to hear more from Sam on the news and what’s ahead!

Sources:

https://www.prnewswire.com/news-releases/interplay-learning-closes-growth-investment-from-goldman-sachs-alternatives-and-acquires-industrial-training-international-302252417.html

https://www.interplaylearning.com/

https://www.iti.com/

Music Credit: Chapter One by Cole Bauer and Dean Keeton

https://www.instagram.com/deankeeton/?hl=en

Disclosure:

The views, statements, and opinions, expressed herein by the hosts and guests are their own, and their appearance on the podcast should not be construed as reflecting the views or implied endorsement of Independent Brokerage Solutions LLC or any of its officers, employees, or agents. The statements made herein should not be considered an investment opinion, advice, or a recommendation regarding securities of any company. This podcast is produced solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy a security.

Our Social Media Pages, follow us and engage with the Pill-grim community!

Instagram

Twitter

YouTube

TikTok

LinkedIn

And now for this week’s prescription:

On this week’s dose, we start (1:44) with a breakdown on Aifleet, an Austin-based trucking startup that uses AI to optimize routes and load planning, which just announced a $16.6M Series B led by Tom Williams. Then (6:57), we have a Pillfolio Update on Viome, a startup that leverages AI and data to offer people personalized nutrition guidance through the lens of gut health, fresh off a $25M Series D. Lastly (15:43), we close out this week’s dose with a deepdive on LineLeap, a startup that lets people pay to skip lines at popular venues, hot off a $10M funding round.

Sources:

https://aifleet.com/

https://siliconangle.com/2024/09/10/aifleet-raises-16-6m-scale-ai-driven-trucking-solutions/

https://www.viome.com/

https://longevity.technology/news/viome-lands-25m-to-launch-new-diagnostics-division/

https://www.lineleap.com/

https://techcrunch.com/2024/09/11/lineleap-lets-users-pay-to-skip-the-line-at-bars/

Music Credit: Chapter One by Cole Bauer and Dean Keeton

https://www.instagram.com/deankeeton/?hl=en

Disclosure:

The views, statements, and opinions, expressed herein by the hosts and guests are their own, and their appearance on the podcast should not be construed as reflecting the views or implied endorsement of Independent Brokerage Solutions LLC or any of its officers, employees, or agents. The statements made herein should not be considered an investment opinion, advice, or a recommendation regarding securities of any company. This podcast is produced solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy a security.